Pediatric glaucoma: Glaucoma medications and steroids

Abstract

The majority of medications used for IOP-lowering in adults are not licensed for use in children. Package inserts on topical medications warn that safety and efficacy has not been established in children. Despite this fact, most topical drops are used in children and are safe. Definitive trials to establish their safety and efficacy are unlikely to occur due to medicolegal constraints, namely, the difficulty in establishing accurate outcome measurements, limited sample sizes, and low financial incentives to drug companies evaluating pro-ducts in the pediatric population [1]. © 2010 Springer-Verlag Berlin Heidelberg.